
Um ensaio controlado randomizado de uma intervenção de saúde digital multimodalidade para auxiliar o fornecimento da dieta cetogênica modificada para epilepsia: Protocolo de ensaio Keto eCoach
NeurologiaResumo original em inglês
O que aconteceu
Dietary therapy is an effective treatment for drug-resistant epilepsy; however, low adherence presents a significant barrier to use in the clinical setting. This study aims to evaluate a multimodality digital health intervention to overcome this barrier and improve outcomes in adults undertaking the modified ketogenic diet for epilepsy.
This is a two-arm, randomized, controlled trial. A total of 136 participants will be randomized 1:1 to receive the modified ketogenic diet as per standard clinical care, or with the addition of the multimodality digital health intervention for 12 weeks. The intervention will include three components: (1) digital diaries, (2) a novel, at-home, saliva-based ketone testing device, and (3) dynamic dietitian support.
This study has received approval from the Alfred Hospital Human Research Ethics Committee (Reference No.: 723/23). The results will be disseminated via peer-reviewed publications and publicly available plain language summaries.
Australian New Zealand Clinical Trials Registry (ANZCTR, ACTRN12624000486527).
This trial aims to find out if a 12-week digital health program can improve treatment outcomes of people living with epilepsy. We will invite 136 people commencing on the modified ketogenic diet to be randomly assigned to the digital health program or standard clinic care. The treatment outcome will be assessed combining seizure frequency, side effects, and quality of life.
O que encontraram
The primary treatment benefit will be determined using the epilepsy desirability of outcome rank, a composite outcome measure co-designed with people living with drug-resistant epilepsy. Secondary outcomes will include seizure frequency, treatment retention, adverse events, psychiatric symptoms, quality of life, medication use, cost effectiveness, and acceptability of the intervention.
Por que isso importa
The results of this trial will provide evidence on the effectiveness of using this innovative digital health intervention approach to improve treatment outcomes of dietary therapy for drug-resistant epilepsy.
Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.
O estudo original
A randomized controlled trial of a multimodality digital health intervention to aid the delivery of the modified ketogenic diet therapy for epilepsy: The Keto eCoach trial protocol
Neha Kaul, Lucy Vivash, Susanna Chen, Lillian King, Hannah Johns, Leonid Churilov, Zhibin Chen, John-Paul Nicolo, Danielle Heaven, Ella Meredith et al.
Descritores MeSH
- Drug Resistant Epilepsy
- Diet, Ketogenic
- Adult
- Humans
- Quality of Life
- Randomized Controlled Trials as Topic
- Treatment Outcome
- Digital Health
Veja também
Estudos relacionados
- Modified Atkins Diet versus low glycemic index treatment in children with drug-resistant epilepsy: A systematic review and meta-analysis
- Efeitos de Intervenções Digitais na Melhoria de Sintomas e Qualidade de Vida em Pacientes com Bexiga Sobreativa: Revisão Sistemática e Meta-Análise
- Eficácia e Segurança dos Medicamentos Anti-Obesidade para Manutenção da Perda de Peso em Adultos com Sobrepeso ou Obesidade: Revisão Sistemática e Meta-Análise de Ensaios Controlados Randomizados
- Eficácia comparativa da terapia de ativação barorreflexa, modulação da contratilidade cardíaca e terapia de ressincronização cardíaca em insuficiência cardíaca com fração de ejeção reduzida: revisão sistemática e metanálise em rede de ensaios controlados randomizados